These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
789 related articles for article (PubMed ID: 32146302)
1. Death related to nicotine replacement therapy: A case report. Tjoncke JA; Goncalves R; Castaing N; Molimard M; Tovagliaro F; Titier K Forensic Sci Int; 2020 Apr; 309():110223. PubMed ID: 32146302 [TBL] [Abstract][Full Text] [Related]
3. Self-poisoning among adults using multiple transdermal nicotine patches. Woolf A; Burkhart K; Caraccio T; Litovitz T J Toxicol Clin Toxicol; 1996; 34(6):691-8. PubMed ID: 8941198 [TBL] [Abstract][Full Text] [Related]
4. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS J Clin Pharmacol; 1998 Jun; 38(6):502-9. PubMed ID: 9650539 [TBL] [Abstract][Full Text] [Related]
5. Death due to ingestion of nicotine-containing solution: case report and review of the literature. Solarino B; Rosenbaum F; Riesselmann B; Buschmann CT; Tsokos M Forensic Sci Int; 2010 Feb; 195(1-3):e19-22. PubMed ID: 19954906 [TBL] [Abstract][Full Text] [Related]
6. Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk. Ilett KF; Hale TW; Page-Sharp M; Kristensen JH; Kohan R; Hackett LP Clin Pharmacol Ther; 2003 Dec; 74(6):516-24. PubMed ID: 14663454 [TBL] [Abstract][Full Text] [Related]
7. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Fredrickson PA; Hurt RD; Lee GM; Wingender L; Croghan IT; Lauger G; Gomez-Dahl L; Offord KP Psychopharmacology (Berl); 1995 Dec; 122(3):215-22. PubMed ID: 8748390 [TBL] [Abstract][Full Text] [Related]
13. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial. Walker N; Parag V; Verbiest M; Laking G; Laugesen M; Bullen C Lancet Respir Med; 2020 Jan; 8(1):54-64. PubMed ID: 31515173 [TBL] [Abstract][Full Text] [Related]
14. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757 [TBL] [Abstract][Full Text] [Related]
15. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791 [TBL] [Abstract][Full Text] [Related]
16. Long-term nicotine substitution after application of a 16-hour nicotine patch in smoking cessation. Nørregaard J; Tønnesen P; Simonsen K; Säwe U Eur J Clin Pharmacol; 1992; 43(1):57-60. PubMed ID: 1505610 [TBL] [Abstract][Full Text] [Related]
17. Programmable transdermal delivery of nicotine in hairless guinea pigs using carbon nanotube membrane pumps. Paudel KS; Wu J; Hinds BJ; Stinchcomb AL J Pharm Sci; 2012 Oct; 101(10):3823-32. PubMed ID: 22806243 [TBL] [Abstract][Full Text] [Related]
18. Predicting smoking cessation. Who will quit with and without the nicotine patch. Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790 [TBL] [Abstract][Full Text] [Related]
20. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Benowitz NL; Zevin S; Jacob P Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]